Diagnostics involves investigating and discovering certain diseases, conditions and injuries by closely studying various symptoms and indications displayed by patients. In broad terms, today’s Diagnostics Industry breaks down into the following categories, namely in-vitro diagnostics (IVD) (examination of diverse tissue samples in a laboratory) and in-vivo diagnostics (observation and testing of tissue and any organ’s functioning by exploiting the techniques like medical (diagnostic) imaging and monitoring).
A nearly EUR 37.5 billion sector, in-vitro diagnostics promises enormous growth potential, with governments increasingly redefining soaring healthcare spending and starting to pour investments into the high tech diagnostics business. The latter continues to be superintended by a mere scattering of behemoths. Major forces fuelling the industry development include, among others, innovative approaches regarding equipment and clinical trial activities.
This Catalogue presents an invaluable collection of research reports examining the Diagnostics and Diseases Market worldwide, by various regions and selected countries. The research reports feature market sizing analyses and growth rate reviews, discussions of factors diving or deterring the growth of the Diagnostics and Diseases Industry, information on market dynamics and share, etc. The profiles of large-to-micro caps, and the Diagnostics and Diseases Market forecasts are provided in the research reports too.
Publications found:
43,378
Sort by:
2024 Albania Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor--Country Database and Analysis--2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
US$ 1,450.00
This new report from LeadingMarketResearch.com is available by market segment, section, individual marker, and can be customized to specific information needs and budget. This report is designed to as...
January 2024
2024 Argentina Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor--Country Database and Analysis--2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
US$ 1,450.00
This new report from LeadingMarketResearch.com is available by market segment, section, individual marker, and can be customized to specific information needs and budget. This report is designed to as...
January 2024
2024 Asia-Pacific Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor-- An 18-Country Database and Analysis, 2023 2023 Supplier Shares and Strategies, 2023-2028 2023-2028 Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
US$ 6,500.00
This new 18-country report from LeadingMarketResearch.com is available by country, market segment, section, individual marker, and can be customized to specific information needs and budget. This repo...
January 2024
2024 Australia Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor--Country Database and Analysis--2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
US$ 1,450.00
This new report from LeadingMarketResearch.com is available by market segment, section, individual marker, and can be customized to specific information needs and budget. This report is designed to as...
January 2024
2024 Austria Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor--Country Database and Analysis--2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
US$ 1,450.00
This new report from LeadingMarketResearch.com is available by market segment, section, individual marker, and can be customized to specific information needs and budget. This report is designed to as...
January 2024
2024 Bahrain Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor--Country Database and Analysis--2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
US$ 1,450.00
This new report from LeadingMarketResearch.com is available by market segment, section, individual marker, and can be customized to specific information needs and budget. This report is designed to as...
January 2024
2024 Bangladesh Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor--Country Database and Analysis--2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
US$ 1,450.00
This new report from LeadingMarketResearch.com is available by market segment, section, individual marker, and can be customized to specific information needs and budget. This report is designed to as...
January 2024
2024 Belarus Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor--Country Database and Analysis--2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
US$ 1,450.00
This new report from LeadingMarketResearch.com is available by market segment, section, individual marker, and can be customized to specific information needs and budget. This report is designed to as...
January 2024
2024 Belgium Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor--Country Database and Analysis--2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
US$ 1,450.00
This new report from LeadingMarketResearch.com is available by market segment, section, individual marker, and can be customized to specific information needs and budget. This report is designed to as...
January 2024
2024 Bolivia Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor--Country Database and Analysis--2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
US$ 1,450.00
This new report from LeadingMarketResearch.com is available by market segment, section, individual marker, and can be customized to specific information needs and budget. This report is designed to as...
January 2024
2024 Brazil Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor--Country Database and Analysis--2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
US$ 1,450.00
This new report from LeadingMarketResearch.com is available by market segment, section, individual marker, and can be customized to specific information needs and budget. This report is designed to as...
January 2024
2024 Bulgaria Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor--Country Database and Analysis--2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
US$ 1,450.00
This new report from LeadingMarketResearch.com is available by market segment, section, individual marker, and can be customized to specific information needs and budget. This report is designed to as...
January 2024
2024 Canada Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor--Country Database and Analysis--2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
US$ 1,450.00
This new report from LeadingMarketResearch.com is available by market segment, section, individual marker, and can be customized to specific information needs and budget. This report is designed to as...
January 2024
2024 Chile Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor--Country Database and Analysis--2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
US$ 1,450.00
This new report from LeadingMarketResearch.com is available by market segment, section, individual marker, and can be customized to specific information needs and budget. This report is designed to as...
January 2024
2024 China Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor--Country Database and Analysis--2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
US$ 1,450.00
This new report from LeadingMarketResearch.com is available by market segment, section, individual marker, and can be customized to specific information needs and budget. This report is designed to as...
January 2024
2024 Colombia Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor--Country Database and Analysis--2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
US$ 1,450.00
This new report from LeadingMarketResearch.com is available by market segment, section, individual marker, and can be customized to specific information needs and budget. This report is designed to as...
January 2024
2024 Costa Rica Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor--Country Database and Analysis--2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
US$ 1,450.00
This new report from LeadingMarketResearch.com is available by market segment, section, individual marker, and can be customized to specific information needs and budget. This report is designed to as...
January 2024
2024 Croatia Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor--Country Database and Analysis--2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
US$ 1,450.00
This new report from LeadingMarketResearch.com is available by market segment, section, individual marker, and can be customized to specific information needs and budget. This report is designed to as...
January 2024
2024 Cuba Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor--Country Database and Analysis--2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
US$ 1,450.00
This new report from LeadingMarketResearch.com is available by market segment, section, individual marker, and can be customized to specific information needs and budget. This report is designed to as...
January 2024
2024 Cyprus Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor--Country Database and Analysis--2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
US$ 1,450.00
This new report from LeadingMarketResearch.com is available by market segment, section, individual marker, and can be customized to specific information needs and budget. This report is designed to as...
January 2024
2024 Czech Republic Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor--Country Database and Analysis--2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
US$ 1,450.00
This new report from LeadingMarketResearch.com is available by market segment, section, individual marker, and can be customized to specific information needs and budget. This report is designed to as...
January 2024
2024 Denmark Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor--Country Database and Analysis--2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
US$ 1,450.00
This new report from LeadingMarketResearch.com is available by market segment, section, individual marker, and can be customized to specific information needs and budget. This report is designed to as...
January 2024
2024 Dominican Republic Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor--Country Database and Analysis--2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
US$ 1,450.00
This new report from LeadingMarketResearch.com is available by market segment, section, individual marker, and can be customized to specific information needs and budget. This report is designed to as...
January 2024
2024 Ecuador Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor--Country Database and Analysis--2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
US$ 1,450.00
This new report from LeadingMarketResearch.com is available by market segment, section, individual marker, and can be customized to specific information needs and budget. This report is designed to as...
January 2024
2024 El Salvador Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor--Country Database and Analysis--2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
US$ 1,450.00
This new report from LeadingMarketResearch.com is available by market segment, section, individual marker, and can be customized to specific information needs and budget. This report is designed to as...
January 2024
2024 Estonia Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor--Country Database and Analysis--2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
US$ 1,450.00
This new report from LeadingMarketResearch.com is available by market segment, section, individual marker, and can be customized to specific information needs and budget. This report is designed to as...
January 2024
2024 Europe Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor-- A 38-Country Database and Analysis, 2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
US$ 7,500.00
This new 38-country report from LeadingMarketResearch.com is available by country, market segment, section, individual marker, and can be customized to specific information needs and budget. This repo...
January 2024
2024 Europe Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor--France, Germany, Italy, Spain, UK--2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
US$ 3,500.00
This new 5-country report from LeadingMarketResearch.com is available by country, market segment, section, individual marker, and can be customized to specific information needs and budget. This repor...
January 2024
2024 Finland Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor--Country Database and Analysis--2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
US$ 1,450.00
This new report from LeadingMarketResearch.com is available by market segment, section, individual marker, and can be customized to specific information needs and budget. This report is designed to as...
January 2024
2024 France Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor--Country Database and Analysis--2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
US$ 2,450.00
This new report from LeadingMarketResearch.com is available by market segment, section, individual marker, and can be customized to specific information needs and budget. This report is designed to as...
January 2024
2024 Georgia Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor--Country Database and Analysis--2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
US$ 1,450.00
This new report from LeadingMarketResearch.com is available by market segment, section, individual marker, and can be customized to specific information needs and budget. This report is designed to as...
January 2024
